Website update in progress

Following the transformation of Polpharma Biologics (learn more), this site will focus on biosimilars development in Switzerland. In Poland, we operate now as Rezon Bio – a contract developer and manufacturer of biologics (CDMO). More at www.rezonbio.com.

Due to the demerger of Polpharma Biologics into two independent companies (detailed information can be found in the “Knowledge center” section), the website polpharmabiologics.com is currently being updated. For details on the CDMO business, please visit the Rezon Bio website

Go to Rezon Bio website
Logo European Union

BioFuture Challenge

Competition for postgraduate studies organized by SGGW & Polpharma Biologics

Effective knowledge transfer between science and business is key to driving innovation in biotechnology.
That’s why Polpharma Biologics and Warsaw University of Life Sciences (SGGW) invites you to take part in the unique BioFuture Challenge, a competition that offers a chance to bridge theory with hands-on experience in the production and commercialization of biosimilar medicines.

BioFuture Challenge – Meet the Winners

We have concluded the first edition of the BioFuture Challenge. Among many inspiring applications, the jury selected two people who will receive fully-funded places in the postgraduate program Pharmaceutical Biotechnology: development and production of biosimilar drugs

Winners:

  • Ms. Anna Zinkow for the paper prepared in the topic - Next-Generation Antibodies: Bispecifics and Beyond
  • Mr. Artur Nieszporek for the paper prepared in the topic - The Role of Artificial Intelligence in Designing New Antibody Therapies/or in biotechnology

Congratulations!

 

What are the rewards?

Two fully-funded places in the postgraduate program
Pharmaceutical Biotechnology: development and production of biosimilar drugs

Why are these studies important?

  1. Practical skills and the latest knowledge in biotechnology
  2. Combining theory with the practice of drug development and production
  3. Classes led by industry experts and experienced scientists
  4. The ideal career path in the industry of the future

What should you do to participate in the competition?

1. Choose a competition topic

Next-Generation Antibodies: Bispecifics and Beyond

or

The Role of Artificial Intelligence in Biotechnology

2. Send your competition entry

by April 30, 2025

to: bio.future.challenge@polpharmabiologics.com In the body of your e-mail, specify the topic of your choice.

3. Send your completed work

by May 30, 2025

 

to: bio.future.challenge@polpharmabiologics.com

4. Results will be announced

June 17, 2025!

Follow our profiles on Linkedin: Polpharma Biologics and SGGW

Who will evaluate the submissions?

Expert Committee:

  1. Prof. Marcin Filipecki – representing SGGW – decisive vote
  2. Prof. Katarzyna Wiktorska – representing SGGW
  3. Konstantin Matentzoglu – representing Polpharma Biologics
  4. Alicja Kryczało-Lara – representing Polpharma Biologics
  5. Srdjan Picuric – representing Polpharma Biologics

What will the jury take into account when evaluating the submissions?

Competition criteria:

  1. Compatibility with the competition theme
  2. Innovation and originality
  3. Scientific accuracy and relevance
  4. Quality of argumentation and analysis

NOTE: Competition entries must be prepared in English

Competition Regulations

You can find the full terms and conditions, evaluation criteria, information on personal data processing (GDPR), and copyright transfer here: Download the regulations

Formats of Competition Submissions

  1. Written essay:
    text document (.doc, .docx, .pdf) maximum 10 A4 pages, Times New Roman font, size 12, spacing 1.5.
  2. Presentation:
    in PowerPoint (.ppt, .pptx) or PDF, maximum 8 slides
  3. Podcast:
    maximum 15 minutes (MP3, WAV)
  4. Video:
    maximum 8 minutes (MP4, MOV or AVI)